Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer reported by R. Vonmoos et al
August 14th, 2008
According to recent research from Chur, Switzerland, "Clinical data show that a single, 15-min i.v. infusion of ibandronate 6 mg does not significantly alter renal function. We evaluated the effect on renal function of repeated 15-min infusions of ibandronate 6 mg in women with breast cancer and bone metastases." "Patients were randomly assigned to i.v. ibandronate 6 mg every 3-4 weeks for <= 6 months, infusion over 15 min (n = 102) or 60 min (n = 28). The primary end point was the percentage of patients with increased serum creatinine of >= 44.2 mu mol/l. Blood chemistry was assessed at each visit. Two per cent [2/101; 95% confidence interval (CI) 0.2-7.0] of...
Source: Women's Health Weekly (2008-08-14)
|
